CLPS Inc financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data CLPS Inc files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2018	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	29	31.4	48.9	64.9	89.4	126	152	150	143	164
Cost of revenue	17.5	18.7	31.3	41.2	58.3	85.9	111	116	110	128
Gross profit	11.6	12.7	17.7	23.8	31.1	40.2	41	34.5	32.9	36.3
Research and development	5.58	4.23	7.84	7.98	10.4	13.3	7.97	8.34	7.16	5.82
Selling and marketing	0.41	1.21	2.23	2.18	3.06	3.75	4.1	3.3	4.57	5.18
General and administrative	4.96	5.65	5.87	17.4	16.3	16.8	23	21.6	25.1	31.9
Operating expenses	10.9	11.1	15.9	26.8	27.9	31.8	33.6	34.4	35.5	41.7
Operating income	0.61	1.61	1.73	-3.09	3.21	8.38	7.41	0.08	-2.54	-5.38
Interest expense			0.08	0.1	0.09	0.16	0.45	0.37
Pre-tax income	2.05	2.1	2.6	-3.1	3.71	8.32	7.68	0.77	-1.84	-5.08
Income tax	0.27	-0.12	-0.11	0.19	0.84	1.26	3.05	0.67	0.16	0.95
Net income to minority interests	-0.04	0.17	0.28	-0.16	0.14	0.2	0.13	-0.03	0.48	0.62
Net income	1.78	2.22	2.71	-3.43	3.08	6.82	4.46	0.19	-2.33	-7.05
EBITDA	0.67	1.75	1.93	-2.69	3.8	9.05	8.32	1.3	-1.29	-3.5
EPS, basic	0.16	0.18	0.21	-0.24	0.20	0.39	0.21	0.01	-0.09	-0.26
EPS, diluted	0.16	0.18	0.21	-0.24	0.20	0.39	0.21	0.01	-0.09	-0.26
Shares, basic (weighted)	11.3	11.3	11.5	13.8	14.7	17.3	20.9	23.2	25.2	27.5
Shares, diluted (weighted)	11.3	11.3	11.6	13.8	14.7	17.6	21.1	23.2	25.2	27.5

Balance sheet

	FY2016	FY2018	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	5.28	4.81	9.74	6.6	12.7	24.7	18.4	22.2	29.1	28.2
Short-term investments				1.79	0.64	4.16			2.1	0.9
Receivables		6.64	16.3	19.3	25.8	44.1	53.8	48.5	38.8	44.9
Other current assets		0.58	1.23	1.03	1.28	2.53	0.38	0.39	4.5	7.44
Total current assets		12.3	29.1	29.7	40.5	76.1	76.8	72.9	78.1	85.8
Property, plant and equipment		0.27	0.33	0.57	0.45	0.6	20.6	20.1	21.2	21.2
Lease right-of-use assets								0.82	2.78	3.41
Goodwill		0.2	0.17	0.45	2.12	2.44	2.36		1.47	1.44
Intangible assets		0.31	0.26	0.43	1.14	1.05	0.97	0.73	2.25	2.06
Long-term investments				0.91	0.68	1.01	0.61	0.46	0.61	1.72
Total assets		13.5	30.9	32.7	45.4	82.7	102	95.3	110	118
Accounts payable							0.34	0.69	0.95	2.52
Accrued liabilities		5.39	7.34	7.74	11.5	12.5	12.2	10.6	9.94	14.1
Deferred revenue		0.11	0.2	0.12	0.76	0.33	0.59	0.92	1.14	2.47
Short-term debt			2.55	2.18	2.18	7.55	14.5	10.6	23.2	30.2
Total current liabilities		8.21	12.8	11.3	16.4	23	30.4	26.3	39.8	54.4
Long-term debt					0.02	0.01
Lease liabilities								0.1	1.64	1.3
Other non-current liabilities					0.19	1.8	0.96	0.89	0.88	0.9
Total liabilities		8.21	12.8	11.3	16.7	25	34.1	29.8	46.1	60.5
Total debt					0.02	0.01
Paid-in capital		7.12	17.3	24.3	28.6	48.5	55.7	58.2	61.4	60.2
Retained earnings		-2.52	-0.52	-4.51	-2.68	2.73	6.32	5.03	-0.05	-7.4
Other comprehensive income		-0.45	-0.4	-0.81	-1.36	1.23	-0.55	-3.99	-4.35	-3.1
Shareholders' equity		4.83	18.2	20.8	27.3		66.6	64.6	62.5	55.5
Minority interests		0.48	0	0.61	1.27	1.04	1.25	0.93	1.41	2.05
Total equity	4.21	5.31	18.2	21.4	28.6	57.7	67.8	65.5	63.9	57.6
Total liabilities and equity		13.5	30.9	32.7	45.4	82.7	102	95.3	110	118
Shares outstanding		11.3	13.6	13.9	15.9	20.3	22.4	23.7	25.6	28

Cash flow statement

	FY2016	FY2018	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	1.78	2.22	2.71	-3.43	3.08	7.02	4.59	0.17	-1.85	-6.43
Depreciation and amortization	0.05	0.14	0.21	0.4	0.59	0.68	0.91	1.22	1.25	1.88
Stock-based compensation				7.02	4	5.13	7.18	2.48	3.17	2.47
Deferred income tax	-0.1	-0.22	-0.21	0.1	0.17	-0.41	0.25	0.26	-0.72	0.48
Change in receivables	1.05	-2.41	-9.75	-3.06	-6.6	-16.7	-12.3	0.45	7.21	-5.35
Change in payables	0.03	0.05	0.59	-0.43	0.06	-0.02	0.11	0	-0.19	-0.38
Cash from operations	4.46	0.62	-4.77	0.4	5.93	-2.61	3.2	9.71	8.93	-2.54
Capital expenditures	-0.33	-0.06	-0.23	-0.5	-0.17	-1.07	-20.8	-0.52	-2.12	-1.26
Acquisitions									-2.36	-0.21
Purchases of investments				-1.8				-14.1	-3.22	-1.46
Cash from investing	-0.37	-0.1	-0.49	-3.86	0.17	-5.62	-16.3	-0.31	-12.3	-1.75
Stock issued						14.7	0
Dividends paid	-5.28	-0.74	-0.61			-0.03		-1.18	-2.55	-3.64
Cash from financing	-0.38	-0.83	10.1	0.47	0.13	19.3	7.47	-4.32	10.2	2.9
Exchange rate effect	-0.23	-0.15	0.09	-0.15	-0.18	0.98	-0.73	-1.18	-0.03	0.43
Net change in cash	3.48	-0.46	4.93	-3.14	6.05	12.1	-6.34	3.9	6.84	-0.97
Free cash flow	4.13	0.56	-5	-0.1	5.76	-3.68	-17.5	9.19	6.81	-3.8
Interest paid			0.07	0.07	0.09	0.15	0.34	0.37	0.41	0.48
Income taxes paid	0.29	0.34	0.33	0.77	1.17	1.75	0.68	1.62	0.86	0.38

Key metrics

Worked out from the statements above. Latest values use fiscal 2025. Valuation uses the share price of $1.03 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	22.1%	Gross profit / revenue.
Operating margin	-3.3%	Operating income / revenue.
EBITDA margin	-2.1%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	-3.1%	Pre-tax income / revenue.
Net margin	-4.3%	Net income / revenue.
FCF margin	-2.3%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	-1.5%	Cash from operations / revenue.
Return on equity (ROE)	-11.9%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	-6.2%	Net income / average total assets.
Return on invested capital (ROIC)	-14.0%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	3.5%	Research and development expense / revenue.
Stock-based pay / revenue	1.5%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	0.8%	Capital expenditures / revenue.
D&A / revenue	1.1%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	15.2%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	2.7%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	13.0%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	10.2%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-4.0%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	3.1%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-128.5%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow growth, 1y	-155.8%	Free cash flow vs the same period a year earlier. Only from a positive base.
Book value growth, 1y	-11.2%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-5.9%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	15.2%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	7.3%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	5.1%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	21.1%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	9.2%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	9.4%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	13.4%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.58x	Current assets / current liabilities.
Quick ratio	1.36x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.53x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	51.2%	Total liabilities / total assets.
Working capital	$31.4M	Current assets - current liabilities.
Goodwill and intangibles / assets	3.0%	(Goodwill + intangible assets) / total assets.
Tangible book value	$52.0M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.44x	Revenue / average total assets.
Fixed asset turnover	7.76x	Revenue / average property, plant and equipment.
Receivables turnover	3.93x	Revenue / average receivables.
Days sales outstanding	93 days	365 x average receivables / revenue.
Days payables	5 days	365 x average accounts payable / cost of revenue.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$0.26	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic	-$0.26	Net income per basic share, as reported (split-adjusted).
Revenue per share	$5.97	Revenue / diluted weighted shares.
FCF per share	-$0.14	Free cash flow / diluted weighted shares.
Operating cash flow per share	-$0.09	Cash from operations / diluted weighted shares.
Book value per share	$1.98	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$1.86	Tangible book value / shares outstanding.
Cash per share	$1.04	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$30.5M	Share price x shares outstanding.
Enterprise value	$1.4M	Market cap + total debt - cash - short-term investments.
P/S	0.19x	Market cap / revenue.
P/B	0.55x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	0.59x	Market cap / tangible book value, when positive.
EV/Sales	0.01x	Enterprise value / revenue.
FCF yield	-12.5%	Free cash flow / market cap.
Earnings yield	-23.1%	Net income / market cap (the inverse of P/E).
Dividend yield	11.9%	Dividends paid over the period / market cap.
Shareholder yield	11.9%	(Dividends paid + share buybacks) / market cap.

What was CLPS Inc's revenue in fiscal 2025?

CLPS Inc reported revenue of $164.5M for fiscal 2025, 15.2% higher than the year before.

Was CLPS Inc profitable in fiscal 2025?

No. It reported a net loss of $7.0M.

How much free cash flow did CLPS Inc generate in fiscal 2025?

Cash from operations of $2.5M minus capital expenditures of $1.3M left free cash flow of -$3.8M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to CLPS Inc